FFRct vs Zio XT ECG Monitoring System
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 60/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
FFRct is designed for non-invasive diagnosis of coronary artery disease by analyzing CCTA scans to assess blood flow and identify blockages. In contrast, the Zio XT ECG Monitoring System is a wearable device for continuous cardiac monitoring, primarily focused on detecting and diagnosing arrhythmias. While both leverage AI in cardiology, they address distinct diagnostic needs related to different types of heart conditions.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
HeartFlow FFRct Analysis is a non-invasive AI-powered diagnostic tool designed to assess blood flow in coronary arteries from CCTA scans, aiding in the diagnosis of coronary artery disease. The Zio XT ECG Monitoring System offers continuous cardiac monitoring for up to 14 days to detect and diagnose cardiac arrhythmias.
FFRct utilizes AI and computational fluid dynamics to create personalized 3D models of coronary arteries from CCTA scans and analyze blood flow. Zio XT employs a wearable single-lead ECG biosensor and an FDA-cleared deep-learned AI algorithm to continuously monitor and analyze ECG data for arrhythmia detection.
HeartFlow FFRct Analysis is cloud-based, utilizing the HeartFlow Network, AWS Cloud, or Virtual Private Cloud, with a local Virtual Appliance required for data transfer. The Zio XT ECG Monitoring System is entirely cloud-based on the AWS EC2 platform, requiring no on-premise hardware.
FFRct Analysis is non-invasive, relying on data from a standard CCTA scan. The Zio XT system involves patients wearing a water-resistant, single-lead ECG biosensor for up to 14 days, allowing for normal daily activities including showering, and features a patient-activated button for symptomatic event logging.
The CMS payment rate for FFRct Analysis is $1,017 (2025), with commercial payer rates varying. For the Zio XT service in the US, Medicare rates under CPT codes 93247 and 93243 were proposed at approximately $229-$260.35.
HeartFlow FFRct Analysis is primarily designed for Cardiology and Radiology specialties. The Zio XT ECG Monitoring System is applicable across Cardiology, Emergency Medicine, and Internal Medicine.
More Comparisons
Backers
Who funded each tool's parent company.